Skip to main content

Rahul A. Parikh, MD, PhD


Publications: Click here

Rank: Associate Professor
Position:
GU Oncology Program Director


Clinical Interests

Adrenal Cancer | Bladder Cancer | Genitourinary Cancer | Kidney Cancer | Penile Cancer | Prostate Cancer | Testicular Cancer | Renal Cell Carcinoma   

Research Interests

Clinical investigator with background in bench research focused on DNA repair pathways in cancer and chemotherapy resistance. Specifically, I am evaluating the role of an unregulated ATR-CHEK1 pathway in the development of resistance to chemotherapy and radiation therapy in bladder cancer. I hold multiple patents (US 8,173,366 B2, US 8,263,329 and US 8,466,123) for my research titled "Genetic Changes in ATM and ATR/CHEK1 as Prognostic Indicators in Cancer."


Education and Training

Medical School: Seth G.S. Medical College and K.E.M. Hospital, Mumbai, India
PhD: University of Pittsburgh, PA
Residency: University of Pittsburgh Medical Center, Pittsburgh, PA
Fellowship: University of Pittsburgh Medical Center, Pittsburgh, PA


Organizations

  • University of Kansas Cancer Center
  • Indo-American Cancer Association
  • American Society of Clinical Oncology
  • American Association of Cancer Research
  • American Medical Association
  • Seth G.S. Medical College and KEM Hospital Alumni

Awards 

  • Cancer Clinical Investigator Team Leadership Award (CCITLA) by the NIH-NCI (2017-2019)
  • Alan Winkelstein Award for Fellowship Educator of the Year, University of Pittsburgh Medical Center (2017)
  • David Roodman Excellence in Mentoring Award, University of Pittsburgh Medical Center (2016)
  • Alan Winkelstein Award for Fellowship Educator of the Year, University of Pittsburgh Medical Center (2015)
  • The Stephen Hale Gushée Young Investigator Award, Bladder Cancer Advocacy Network (BCAN) (2015)
Last modified: Sep 03, 2019

Contact

Rahul A. Parikh, MD, PhD

Associate Professor

P: 913-588-1227

Click here

ID=x30272